Home > The Group > About BMJ Group > Partnerships


BMJ Group affiliates itself through partnerships with other healthcare organisations and societies to complement our services and tools so that the patient care and health improvements can be realised worldwide.

Most recently, BMJ Group entered into a major new partnership with the Ministry of Health in Brazil to provide its evidence based clinical decision support tool Best Practice to 350,000 clinicians across the country.

Key government initiatives to promote health and quality of life in Brazil include integrating emergency care services, improving access to low-cost essential medicines, and expanding family health networks to tackle public health issues. The partnership with the BMJ Group will help support the government’s drive for quality improvement and better outcomes for patients.

Other important partnerships include those with MSD and Boots. The partnership with MSD’s medical portal univadis ® will enable BMJ Learning to be available to physicians in 33 countries. The partnership with Boots provides the general public in the UK access to Best Health.


(British National Formulary) and (British National Formulary for Children)

The BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society of Great Britain. It is published biannually under the authority of a Joint Formulary Committee which comprises representatives of the two professional bodies and of the UK Health Departments. The Dental Formulary Subcommittee oversees the preparation of advice on the drug management of dental and oral conditions; the Subcommittee includes representatives of the British Dental Association.

The BNF aims to provide prescribers, pharmacists and other healthcare professionals with sound up-to-date information about the use of medicines.

The BNF includes key information on the selection, prescribing, dispensing and administration of medicines. Medicines generally prescribed in the UK are covered and those considered less suitable for prescribing are clearly identified. Little or no information is included on medicines promoted for purchase by the public.


If you would like more information about licensing digital BNF or BNFC material please contact:electronicinfo@rpsgb.org